BARCLAYS PLC/ GB0031348658 /
23/01/2025 15:21:58 | Chg. +2.15 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
296.15GBX | +0.73% | 575,897 Turnover(GBP): 1.69 mill. |
-Bid Size: - | -Ask Size: - | 44.64 bill.GBP | - | - |
GlobeNewswire
16/05/2024
DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Barclays PLC Investors with Losses in E...
Newsfile Corp
08/05/2024
DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Barclays PLC Investors to Secure Counsel B...
GlobeNewswire
07/05/2024
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Barclays PLC Investors to Secure Counsel Before Important...
GlobeNewswire
29/04/2024
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Imp...
GlobeNewswire
25/04/2024
ROSEN, A LEADING LAW FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Important Dead...
GlobeNewswire
21/04/2024
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Barclays PLC Investors to Secure Counsel Before Importan...
GlobeNewswire
08/04/2024
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Barclays PLC Investors to Secure Counsel Before Importan...
GlobeNewswire
05/04/2024
ROSEN, A LEADING NATIONAL FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Important...
GlobeNewswire
31/03/2024
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Imp...
GlobeNewswire
24/03/2024
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Imp...
GlobeNewswire
11/03/2024
Alumis to Participate in the 2024 Leerink Partners Global Biopharma Conference
GlobeNewswire
29/02/2024
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference